# Jounce Therapeutics

> company

**Wikidata**: [Q106760435](https://www.wikidata.org/wiki/Q106760435)  
**Source**: https://4ort.xyz/entity/jounce-therapeutics

## Summary
Jounce Therapeutics is a public company operating in the pharmaceutical industry, specifically structured as a Delaware corporation. Headquartered in Cambridge, United States, it was founded on January 1, 2013, and trades its securities on the Nasdaq stock exchange under the ticker symbol JNCE. The entity is recognized globally as a business entity with a significant digital footprint across major social media platforms and financial registries.

## Key Facts
- **Legal Form:** Delaware corporation.
- **Industry:** Pharmaceutical industry.
- **Inception Date:** January 1, 2013.
- **Headquarters Location:** Cambridge, United States.
- **Stock Exchange:** Nasdaq (Ticker Symbol: JNCE).
- **Public Status:** Classified as both a "business" and a "public company."
- **Twitter Handle:** @jouncetx (Active since July 13, 2014; ID: 2634724566).
- **Instagram Handle:** @onejounce.
- **Official Website:** http://jouncetx.com/.
- **Central Index Key (CIK):** 0001640455.
- **Bloomberg Company ID:** JNCE:US.
- **Ringgold ID:** 461222 (Registered as "Jounce Therapeutics Inc").
- **Legal Entity Identifier (LEI):** 5493004MZJQIV2K8ZT61.
- **Google Knowledge Graph ID:** /g/11c6cyymtq.
- **Crunchbase Organization ID:** jounce-therapeutics.

## FAQs
**What is the legal and corporate structure of Jounce Therapeutics?**
Jounce Therapeutics is organized as a Delaware corporation, a specific legal form of organization common for US-based businesses. It operates as a public company, meaning its securities are offered for sale to the general public and traded on a major stock exchange.

**Where is Jounce Therapeutics based and how can it be contacted online?**
The company maintains its headquarters in Cambridge, United States. For digital engagement, it operates an official website at http://jouncetx.com/ and maintains active social media profiles on Twitter (@jouncetx) and Instagram (@onejounce).

**How is Jounce Therapeutics identified in global financial and research databases?**
The entity is uniquely identified across multiple financial and academic systems, including the Central Index Key 0001640455, Bloomberg ID JNCE:US, and Ringgold ID 461222. It also holds a Legal Entity Identifier (5493004MZJQIV2K8ZT61) and is indexed in Crunchbase and Google Knowledge Graph under the ID /g/11c6cyymtq.

**When was the company founded and when did it establish its social media presence?**
Jounce Therapeutics was founded on January 1, 2013. Its social media presence began shortly thereafter, with its Twitter account established on July 13, 2014, and its Instagram account also linked to its corporate identity.

## Why It Matters
Jounce Therapeutics represents a critical component of the modern pharmaceutical landscape, utilizing the public company structure to raise capital for drug development and innovation. By listing on the Nasdaq, it provides liquidity for investors and transparency through strict regulatory disclosure standards, which are essential for maintaining trust in the biotech sector. Its existence as a Delaware corporation headquartered in Cambridge places it within a major hub of biotechnology and life sciences, facilitating access to specialized talent and investment networks. The company's comprehensive digital and financial footprint ensures it is easily accessible to researchers, investors, and the public, supporting the broader ecosystem of healthcare advancement.

## Notable For
- Being a publicly traded entity in the pharmaceutical industry with the ticker symbol JNCE on the Nasdaq.
- Operating as a Delaware corporation, a legal structure favored for its business-friendly regulations.
- Maintaining a verified presence on major financial platforms including Bloomberg, Crunchbase, and the SEC (via CIK 0001640455).
- Holding a unique Legal Entity Identifier (LEI) that distinguishes it in global financial transactions.
- Establishing a long-standing social media presence since 2014, specifically on Twitter and Instagram.
- Being recognized in academic and financial databases under the Ringgold ID 461222 as "Jounce Therapeutics Inc."

## Body

### Corporate Identity and Legal Structure
Jounce Therapeutics is formally classified as a business and a public company. It is incorporated as a Delaware corporation, a legal form of organization that defines its governance and liability structure. The entity is registered with the Central Index Key (CIK) 0001640455, which is used for SEC filings and regulatory compliance in the United States. For international financial identification, it holds the Legal Entity Identifier (LEI) 5493004MZJQIV2K8ZT61. In research and library contexts, it is indexed under the Ringgold ID 461222, specifically listed as "Jounce Therapeutics Inc."

### Founding and Operational Timeline
The company was established on January 1, 2013. This inception date marks the beginning of its operations within the pharmaceutical industry. Following its founding, the company expanded its digital outreach, launching its Twitter account on July 13, 2014. The Twitter handle @jouncetx has been associated with the entity since that date, with the account ID 2634724566. The company's official website, http://jouncetx.com/, serves as a primary information hub, with data points verified as of May 7, 2021.

### Financial Market Presence
As a public company, Jounce Therapeutics offers its securities to the general public. Its stock is listed on the Nasdaq stock exchange under the ticker symbol JNCE. This listing allows for the trading of its shares on a public market, distinguishing it from private enterprises. The company is also tracked by Bloomberg with the company ID JNCE:US. These financial identifiers facilitate investment analysis and market monitoring for institutional and individual investors.

### Digital and Social Media Footprint
Jounce Therapeutics maintains a multi-platform digital presence to engage with stakeholders. Beyond its corporate website, the company utilizes Twitter (@jouncetx) and Instagram (@onejounce) for communication. The Instagram handle "onejounce" is linked to the same Google Knowledge Graph ID (/g/11c6cyymtq) as the Twitter account and the Crunchbase profile. These digital assets were verified and referenced in data sources as of May 7, 2021, and May 17, 2021, ensuring the continuity of its online identity.

### Geographic and Industry Context
The company is headquartered in Cambridge, United States, a location known for its concentration of biotechnology and pharmaceutical firms. It operates specifically within the pharmaceutical industry, focusing on the development of therapeutic solutions. Its classification as a public company places it within the broader category of enterprises that are subject to public market regulations and transparency requirements. The entity is recognized globally, with its profile appearing in various international databases and knowledge graphs.

### Data Verification and Sources
The information regarding Jounce Therapeutics is derived from multiple authoritative sources. The Crunchbase organization ID (jounce-therapeutics) and the URL http://www.crunchbase.com/organization/jounce-therapeutics serve as primary references for its founding date and headquarters. Financial data, including the stock exchange listing and ticker symbol, is corroborated by sources referencing the Google Knowledge Graph ID /g/11c6cyymtq and the Wikipedia entity Q648625. The legal form and Ringgold ID are supported by references to Q55259097, with data points updated as of September 17, 2024.

## References

1. [Crunchbase](http://www.crunchbase.com/organization/jounce-therapeutics)
2. Google Knowledge Graph
3. Global LEI Index